At a glance
ClinicalIndex Comparison Record- ✓Daily smokeless tobacco use in the 6 months prior to study entry
- ✓No intention to quit smokeless tobacco within 90 days of study entry
- ✕Current use of tobacco or nicotine products other than smokeless tobacco
- ✕Unstable medical or mental health conditions
- ✕Use of medications that may affect tobacco use or be affected by reduction in tobacco use
- ✕Pregnancy or breastfeeding
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment of Smokeless Tobacco Users
In Brief
A Phase 2 clinical trial evaluating Usual Care Group and Reduction Group for Tobacco Use Disorder. Completed, enrolled 332 participants across 1 site.
Detailed Summary
Smokeless tobacco (ST), which includes both chewing tobacco and snuff, has health risks associated with its use. While treatment programs that focus on stopping tobacco use may be effective, past research has shown that interventions that specifically focus on reducing tobacco use may be equally effective and may motivate individuals to eventually quit using tobacco. This study will compare the effectiveness of a ST reduction treatment program versus a usual tobacco cessation treatment program (immediate cessation) for reducing tobacco use in ST users.
Study Details
Timeline
Interventions
Nicotine replacement therapy
Subject selects preferred method for reduction.